Boehringer Ingelheim Advances Cardio-Kidney-Metabolic Research Through Integrated Therapeutic Development

Pharmacy Times: How does understanding the interconnected nature of heart and kidney health influence how we approach early intervention and long-term risk reduction for cardiovascular events?

Neerja Balachander, MBBS, PhD: All right, let’s…

Continue Reading